These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38894548)

  • 1. CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery.
    Du Z; Xiao Y; Deng G; Song H; Xue Y; Song H
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1587-1600. PubMed ID: 38894548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD19 (+) B Cell Combined with Prognostic Nutritional Index Predicts the Clinical Outcomes of Patients with Gastric Cancer Who Underwent Surgery.
    Sun H; Wang H; Pan H; Zuo Y; Zhao R; Huang R; Xue Y; Song H
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor.
    Deng GM; Song HB; Du ZZ; Xue YW; Song HJ; Li YZ
    World J Gastroenterol; 2024 Feb; 30(8):863-880. PubMed ID: 38516238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a prognostic immunoinflammatory index for patients with gastric cancer.
    Ba ZC; Zhu XQ; Li ZG; Li YZ
    World J Gastroenterol; 2024 Jun; 30(24):3059-3075. PubMed ID: 38983960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy.
    Li Y; Wang WB; Yang L; Wang QY; Dai J; Xia L; Peng J; Zhou FX; Wei YC; Shi HP
    Nutrition; 2022 Jan; 93():111464. PubMed ID: 34678715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort.
    Zhuang CL; Shen X; Huang YY; Zhang FM; Chen XY; Ma LL; Chen XL; Yu Z; Wang SL
    Surgery; 2019 Sep; 166(3):297-304. PubMed ID: 31072665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.
    Liu M; Jin Q; Wang H; Li Y
    Front Immunol; 2024; 15():1396927. PubMed ID: 38690276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
    Findlay M; White K; Brown C; Bauer JD
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients.
    Bir Yucel K; Karabork Kilic AC; Sutcuoglu O; Yazıcı O; Aydos U; Kilic K; Özdemir N
    Nutr Cancer; 2023; 75(1):368-375. PubMed ID: 36093734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.
    Liu A; Zhang G; Yang Y; Xia Y; Li W; Liu Y; Cui Q; Wang D; Yu J
    Cancer Immunol Immunother; 2024 Jun; 73(8):152. PubMed ID: 38833153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of sarcopenia and myosteatosis alterations on survival outcomes for esophageal squamous cell carcinoma before and after radiotherapy.
    Yang N; Zhou P; Lyu J; Ren J; Nie X; Zhao S; Ye Y
    Nutrition; 2024 Nov; 127():112536. PubMed ID: 39182329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.
    Lu D; Hu Z; Chen H; Khan AA; Xu Q; Lin Z; Li H; Zhuo J; He C; Zhuang L; Yang Z; Dong S; Cai J; Zheng S; Xu X
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):2071-2083. PubMed ID: 39192518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nomogram Including Sarcopenia for Predicting Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma: A Retrospective Cohort Study.
    Su W; Wu Y; Liao S; Zhang Z; Zhang Y; Ou W; Yu J; Xiang F; Luo C; Zheng F
    Ann Surg Oncol; 2024 Sep; 31(9):5815-5826. PubMed ID: 38954088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
    Kim M; Lee SM; Son IT; Park T; Oh BY
    Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.